PRVA 250117 60.00C (PRVA250117C60000) Stock Options, News & Quotes

0.70
0.000.00%

15min DelayTrading Jan 17 16:00 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Mar 3, 2024 11:51

Jefferies analysts predict a shift to value-based care as a defining trend in healthcare. They foresee Astrana Health's unique model gaining attention, closing the valuation gap with popular peers. Privia is also praised for its balanced, sustainable earnings growth.

Jefferies Cautious on Value Based Care Providers; Favors ASTH, PRVA, TOI

Moomoo AI

Jan 29, 2024 07:39

Privia Health's CEO, Parth Mehrotra, welcomes Edward C. Fargis, citing his vast experience in corporate governance, compliance and strategic transactions. Fargis is eager to contribute to a profitable growth strategy benefiting stakeholders.

Press Release: Privia Health Appoints Edward C. Fargis as General Counsel

Mooers Radar

May 12, 2023 01:43

Columns Weekly Insider Money Tracking: Director of Privia Health sold $536.47 million shares.

1 | Below is a look at the top insider trades with the biggest value in the past week.
The largest insider trading of this week, which is a sale order of 24,819,473 units, worth over $536.47M, was made by Privia Health director, Daniel Jeffrey Bernstein, on May 10, 2023.
In total, Daniel has made about 4 transactions worth about $1.04B over 2 years at Privia Health Group. The current estimated net worth of Privi...

Moomoo Breakfast US

Aug 31, 2022 07:22

Columns Today's Pre-Market Stock Movers: HPQ, SNAP, CHWY, BBBY and More

Gapping up
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton(Delisted) (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...

Analysts Notebook

May 3, 2022 05:48

Columns Top upgrades and downgrades on 5/3

Upgrades
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...